Versuchen Sie es noch einmal mit einem anderen Suchbegriff
Index | Akt. | Hoch | Tief | +/- | +/- % | Zeit | ||
---|---|---|---|---|---|---|---|---|
Chinext Composite | 2.349,68 | 2.372,75 | 2.344,37 | -19,68 | -0,83% | 30/04 | ||
Chinext Return | 2.015,89 | 2.038,06 | 2.015,21 | -22,22 | -1,09% | 30/04 | ||
SZSE 1000 Growth | 1.154,61 | 1.168,11 | 1.154,56 | -16,76 | -1,43% | 30/04 | ||
SZSE 1000 | 4.619,90 | 4.657,10 | 4.619,89 | -42,34 | -0,91% | 30/04 | ||
SZSE 200 | 3.536,49 | 3.566,73 | 3.532,07 | -24,38 | -0,69% | 30/04 | ||
SZSE 300 Equal Weight | 4.442,88 | 4.479,21 | 4.441,75 | -38,59 | -0,86% | 30/04 | ||
SZSE 300 Growth Price | 2.751,38 | 2.788,15 | 2.751,05 | -46,09 | -1,65% | 30/04 | ||
SZSE 300 Price | 4.063,29 | 4.096,69 | 4.063,26 | -37,57 | -0,92% | 30/04 | ||
SZSE 300 High Beta | 1.426,11 | 1.446,63 | 1.425,26 | -19,31 | -1,34% | 30/04 | ||
SZSE 300 Performance Weighted | 5.506,37 | 5.549,78 | 5.506,24 | -31,05 | -0,56% | 30/04 | ||
SZSE 500 High Beta | 1.203,13 | 1.220,59 | 1.199,21 | -14,34 | -1,18% | 30/04 | ||
SZSE Chinext Equal Weight | 1.384,93 | 1.400,20 | 1.382,58 | -17,17 | -1,22% | 30/04 | ||
SZSE Chinext 300 | 2.674,98 | 2.703,18 | 2.674,15 | -36,15 | -1,33% | 30/04 | ||
Chinext 300 Growth | 2.818,29 | 2.852,68 | 2.817,47 | -40,26 | -1,41% | 30/04 | ||
SZSE Downstream Industry | 5.406,38 | 5.459,41 | 5.406,34 | -19,10 | -0,35% | 30/04 | ||
SZSE Health Care 50 | 8.744,10 | 8.805,23 | 8.690,30 | +9,07 | +0,10% | 30/04 | ||
SZSE Health Care | 9.068,98 | 9.130,83 | 9.012,31 | +14,12 | +0,16% | 30/04 | ||
SZSE Manufacturing | 2.270,55 | 2.286,93 | 2.269,92 | -14,13 | -0,62% | 30/04 | ||
SZSE A Share | 1.836,82 | 1.851,05 | 1.834,46 | -12,95 | -0,70% | 30/04 | ||
SZSE Composite | 1.756,08 | 1.769,66 | 1.753,82 | -12,36 | -0,70% | 30/04 | ||
SME-Chinext 400 | 1.730,91 | 1.747,65 | 1.726,32 | -15,58 | -0,89% | 30/04 | ||
SME-Chinext 500 | 1.587,33 | 1.603,19 | 1.587,03 | -17,90 | -1,12% | 30/04 | ||
SZSE Component Equal Weighted | 3.350,01 | 3.374,22 | 3.346,24 | -25,28 | -0,75% | 30/04 | ||
SME-Chinext Growth | 1.209,00 | 1.224,48 | 1.208,70 | -18,87 | -1,54% | 30/04 | ||
SZSE New | 8.258,15 | 8.320,92 | 8.249,91 | -57,93 | -0,70% | 30/04 | ||
SZSE Chinext Prime Market | 1.757,17 | 1.776,41 | 1.754,92 | -22,28 | -1,25% | 30/04 | ||
SZSE Chinext Strategic Emerging Industries | 2.213,38 | 2.240,10 | 2.212,49 | -37,33 | -1,66% | 30/04 | ||
SZSE Innovation | 3.593,95 | 3.625,98 | 3.585,03 | -32,49 | -0,90% | 30/04 | ||
SZSE Strategic Emerging Industries | 1.857,46 | 1.873,42 | 1.857,25 | -19,38 | -1,03% | 30/04 | ||
SME-Chinext Tec 100 Price | 2.512,69 | 2.544,05 | 2.512,13 | -38,95 | -1,53% | 30/04 | ||
CSI All Share TR | 5.630,979 | 5.630,979 | 5.630,979 | 0,000 | 0,00% | 30/04 | ||
HS China A Pharmaceuticals | 2.614,32 | 2.629,74 | 2.583,95 | +0,00 | +0,00% | 30/04 | ||
HS China A | 1.949,51 | 1.963,34 | 1.949,51 | 0,00 | 0,00% | 30/04 | ||
HS China A Low Size Select | 2.917,05 | 2.937,98 | 2.917,05 | 0,00 | 0,00% | 30/04 | ||
HS China A Value Comprehensive | 3.872,51 | 3.896,77 | 3.872,51 | 0,00 | 0,00% | 30/04 | ||
HS China A Momentum Comprehensive | 4.032,43 | 4.061,82 | 4.032,43 | 0,00 | 0,00% | 30/04 | ||
HS China A Low Size Comprehensive | 2.939,95 | 2.959,55 | 2.939,95 | 0,00 | 0,00% | 30/04 | ||
HS China A Quality Comprehensive | 3.338,06 | 3.361,97 | 3.338,06 | 0,00 | 0,00% | 30/04 | ||
SZSE 500 Health Care | 1.836,50 | 1.849,09 | 1.825,10 | +2,63 | +0,14% | 30/04 | ||
SZSE A Health Care | 1.933,30 | 1.943,68 | 1.916,75 | +9,22 | +0,48% | 30/04 | ||
SZSE A Health Care EW | 2.978,24 | 2.990,00 | 2.824,95 | +40,28 | +1,37% | 30/04 | ||
SZSE Biological Medicine 50 | 2.177,67 | 2.195,02 | 2.170,53 | -11,29 | -0,52% | 30/04 |
Sind Sie sicher, dass Sie %USER_NAME% sperren möchten?
Dadurch werden Sie und %USER_NAME% nicht mehr in der Lage sein, Beiträge des jeweils anderen auf Investing.com zu sehen.
%USER_NAME% wurde erfolgreich zu Ihrer Sperrliste hinzugefügt.
Da Sie diese Person entsperrt haben, müssen Sie 48 Stunden warten, bevor Sie sie wieder sperren können.
Sagen Sie uns Ihre Meinung zu diesem Kommentar
Vielen Dank!
Ihre Meldung wurde zur Überprüfung an unsere Moderatoren geschickt